Publication | Closed Access
Effects of the CYP2D6*10 alleles and co‐medication with CYP2D6‐dependent drugs on risperidone metabolism in patients with schizophrenia
26
Citations
38
References
2009
Year
The CYP2D6*10 polymorphism and the presence of co-medication exerted significant influences on the pharmacokinetics of risperidone.
| Year | Citations | |
|---|---|---|
Page 1
Page 1